Tel.: +323-865-3980, Fax: +323-865-0061
HMG CoA reductase inhibitors, NSAIDs and risk of glioma†
Version of Record online: 4 APR 2012
Copyright © 2012 UICC
International Journal of Cancer
Volume 131, Issue 6, pages E1031–E1037, 15 September 2012
How to Cite
Ferris, J. S., McCoy, L., Neugut, A. I., Wrensch, M. and Lai, R. (2012), HMG CoA reductase inhibitors, NSAIDs and risk of glioma. Int. J. Cancer, 131: E1031–E1037. doi: 10.1002/ijc.27536
This article was published online on 04 April 2012. An error was subsequently identified. This notice is included to indicate that it was corrected 20 July 2012.
- Issue online: 20 JUL 2012
- Version of Record online: 4 APR 2012
- Accepted manuscript online: 15 MAR 2012 05:56AM EST
- Manuscript Accepted: 27 FEB 2012
- Manuscript Received: 28 JUN 2011
- National Cancer Institute. Grant Numbers: T32-CA09529, K05CA89155, R01CA52689, P50CA097257, K07CA127468, K07127468-02S, R01CA139020-27064
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.